RecruitingNCT04512846

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Comparison of Efficacy in Stereotactic Body Radiation Therapy (SBRT) of Large Hepatocellular Carcinoma (5-10 cm) With or Without Transcatheter Arterial Chemoembolization (TACE)


Sponsor

Beijing 302 Hospital

Enrollment

100 participants

Start Date

Aug 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims to compare efficacy and adverse reactions of large hepatocellular carcinoma participants (5-10cm) who receive stereotactic body radiation therapy with or without transcatheter arterial chemoembolization.The investigators will optimize the combined treatment schedule of SBRT for hepatocellular carcinoma participants by comparing overall survival rates, progression-free survival rates and local control and adverse reaction occurrence rates in the two groups.


Eligibility

Min Age: 30 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether combining two liver cancer treatments — targeted radiation (SBRT) with or without a procedure that blocks blood flow to the tumor (TACE) — works better for people with a single large liver tumor. **You may be eligible if...** - You have been diagnosed with primary liver cancer (hepatocellular carcinoma) - You have a single tumor between 5 and 10 cm in size - Your liver function is relatively preserved (Child-Pugh A or B) - You are in reasonably good physical health (able to carry out daily activities) - You are not a candidate for surgery or liver transplant, or have chosen not to pursue those options - You are being treated for hepatitis B or C if applicable **You may NOT be eligible if...** - The cancer has spread to your lymph nodes or other parts of the body - There is a blood clot caused by the tumor in your liver vessels (tumor thrombus) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing 302 hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04512846


Related Trials